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Spacecraft maximum allowable concentrations (SMACs) for C3 to C8, straight-chain, aliphatic 
aldehydes have been previously assessed and have been documented in volume 4 of Spacecraft 
Maximum Allowable Concentrations for Selected Airborne Contaminants (James, 2000).  These 
aldehydes as well as associated physical properties are shown in Table 1.  The C3 to C8 aliphatic 
aldehydes can enter the habitable compartments and contaminate breathing air of spacecraft by 
several routes including incomplete oxidation of alcohols in the Environmental Control and Life 
Support System (ECLSS) air revitalization subsystem, as a byproduct of human metabolism, 
through materials off-gassing, or during food preparation.  These aldehydes have been detected 
in the atmosphere of manned space vehicles in the past.  Analysis performed by NASA of crew 
cabin air samples from the Russian Mir Space Station revealed the presence of C3 to C8 
aldehydes at concentrations peaking at approximately 0.1 mg/m3 (unpublished NASA technical 
data from 1995 reported by James, 2000).   
 
Table 1. Physical Properties of C3 to C8, Straight-chain, Aliphatic Aldehydes 
Name: Propanal Butanal Pentanal Hexanal Heptanal Octanal 
CH3(CH2)nCHO: n = 1 n = 2 n = 3 n = 4 n = 5 n = 6 
CAS nos: 171426-73-6 171339-76-7 110-62-3 66-25-1 111-71-7 124-13-0 
Molecular weights: 58.1 72.1 86.1 100.2 114.2 128.2 
Boiling points (°C): 49 76 103 128 154 171 
Melting point (°C): -81 -99 -92 -56 -45 N/A 
Vapor pressures 
(mmHg): 
687 92 50 10 3 N/A 
(at °C): 45 20 25 20 25  
Conversion factors:†       
1 ppm = 2.3 mg/m3 2.9 3.5 4.1 4.6 5.2 
1 mg/m3 = 0.422 ppm 0.340 0.284 0.245 0.215 0.191 
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CAS, Chemical Abstracts Service 
†  1 ppm converted to milligrams per cubic meter, and 1 mg/m3 converted to parts per million. 
N/A, not available. 
 
The majority of the existing reports pertaining to aliphatic aldehyde toxicity have been 
previously reviewed by NASA in support of establishment of the SMACs published in 2000.  
This report is intended as a companion document to complement and update the existing C3-C8 
saturated aliphatic aldehyde SMAC document.  This update will summarize the approach taken 
in developing the existing SMACs, identify recent data that may impact existing SMAC values, 
and establish and provide rational for a new 1000-day SMAC. 
 
 
REVIEW OF EXISTING SMACs AND SUMMARY OF ORIGINAL APPROACH  
 
The initial review in 2000 resulted in establishment of 1 and 24 hour as well as 7, 30, and 180 
day SMACs for the group of C3 to C8 straight-chained, aliphatic aldehydes.  Table 2 presents 
SMACs established by NASA for these compounds.  Respiratory irritation potential threshold 
(RD50) data from rats and mice indicate similar properties (sensory irritation) within this group of 
compounds and the closely related compound – acetaldehydes (Steinhagen and Barrow, 1984; 
Babiuk et al., 1985; Sim and Pattle, 1957).  Due to the similarity in toxicity exhibited on this 
particular endpoint by the C3 to C8 aldehydes, the Committee on Spacecraft Exposure 
2 
1 
2 
3 
4 
5 
6 
7 
8 
Guidelines chose to establish SMACs for these compounds as a group rather than setting 
separate SMACs.  The toxicological endpoints of concern identified previously include mucosal 
irritation, nasal cavity injury, nausea and vomiting, and liver damage.  SMACs for each exposure 
time were selected based on the most conservative Acceptable Concentration (AC) for each 
toxicological endpoint. 
 
Table 2.  Spacecraft Maximum Allowable Concentrations (SMACs) for C3 to C8 Aliphatic 
Saturated Aldehydes - 2000 
Duration ppm mg/m3 Toxic Endpoint to Avoid 
1 h 50 125-250a Mucosal irritation 
24 h 50 125-250 Mucosal irritation 
7 d 6 15-30 Liver injury, mucosal irritation 
30 d 1.5 4-8 Liver injury 
180 d 1.5 4-8 Liver injury 
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a The value depends on the molecular weight of the aldehyde. 
 
 
Protection against mucosal irritation 
An early study reported irritancy to mucosal surfaces in humans resulting from exposure to 
propanal for 30 minutes (mildly irritating at 134 ppm, Sim and Pattle, 1957).  The same study 
found that exposure to 230 ppm butanal and 207 ppm isobutanal for 30 minutes was not irritating 
to the human subjects.  Human data was only available for the three aldehydes mentioned above.  
However, animal data available at the time indicated the possibility that other aldehydes in the 
group may be two to three times more irritating than propanal (Salem and Cullumbine 1960; 
Abdo et al., 1998).  Thus, ACs for the 1-hr and 24-hr SMACs were set at 50 ppm (Eq. 1). 
 
 Equation 1: 1- and 24-h SMACs based on mucosal irritation. 
 134 ppm (LOAEL) reduced downward by a factor of approximately two to three) 
 1- and 24-h AC(Mucosal irritation) = 50 ppm 
 
Although short-term ACs were established conservatively to protect against mucosal irritation, 
some risk of this toxicological endpoint is allowed.  However, for exposure durations exceeding 
24 h, mucosal irritation should be precluded.  Therefore, the NASA 7, 30, and 180 day SMAC 
was established by dividing the human-derived mildly irritating concentration of 134 ppm (for 
propanal, Sim and Pattle, 1957) by ten, yielding an AC of 13 ppm (James, 2000) (Eq. 2).   
 
 Equation 2: 7-, 30-, and 180-day SMACs based on mucosal irritation.  
 134 ppm (LOAEL) • 1/10 
 7-, 30-, and 180-day AC(Mucosal irritation) = 13 ppm 
   
 
Protection against nasal-cavity injury 
Long-term isobutanal exposure studies in rats and mice were utilized to estimate ACs protective 
for injury to the nasal-cavity (squamous metaplasia and olfactory epithelial degeneration in the 
nose; Abdo, 1998).  In the first study of this report, an isobutanal vapor cumulative exposure 
time of 390 hours (6 h/d, 5 d/wk for up to 13 weeks) resulted in a no observable adverse effect 
level (NOAEL) of 500 ppm in both rats and mice.  Similarly, 500 ppm was reported as the 
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lowest observed adverse effect level (LOAEL) in female rats.  In the second study from this 
report, the cumulative exposure time to isobutanal vapor was 3120 hours (6 h/d, 5 d/wk for 2 
years).  NASA ACs protective of nasal-cavity injury based on the NOAEL and LOAEL values 
from Abdo, 1998 are (Eq. 3, Eq. 4, and Eq. 5): 
 
 Equation 3: 7-day SMAC based on nasal-cavity injury.  
 500 ppm (NOAEL) • 1/10 (species factor) 
 7-day AC(Nasal-cavity injury) = 50 ppm 
  
 Equation 4: 30-day SMAC based on nasal-cavity injury.  
 500 ppm (NOAEL) • 1/10 (species factor) • 390 h/720 h(time extrapolation) 
 30-day AC(Nasal-cavity injury)  = 27 ppm 
 
 Equation 5: 180-day SMAC based on nasal-cavity injury. 
 500 ppm (LOAEL) • 1/3(LOAEL to NOAEL) • 1/10 (species factor) • 3120 h/4320 h(time extrapolation) 
 180-day AC(Nasal-cavity injury)  = 12 ppm 
 
 
Protection against liver injury 
Acceptable Concentrations protective for possible liver injury from accumulation of organic 
acids from aldehyde metabolism were conservatively set at 6.4 ppm (7-day AC) and 1.5 ppm 
(30- and 180-day AC) (James, 2000).  Choice of liver injury as a presumptive toxicological 
endpoint was based on the observation of vacuoles within hepatocytes of rats exposed 6 times to 
1,300 ppm propanal for 6 h each exposure (Gage, 1970).  To derive the ACs, NASA used, as a 
point of departure, the 90 ppm exposure level reported by Gage (20 exposures of 6 h each) to 
yield no observable liver changes (cumulative exposure of 120 hours).  It was assumed that 
harmful metabolites would not accumulate in liver cells below a threshold exposure 
concentration.  Extrapolations to adjust for exposure duration based on application of Haber’s 
rule would correct the AC to a level below this threshold concentration.  The resulting NASA 
ACs protective for liver injury are (Eq. 6 and Eq. 7): 
 
Equation 6: 7-day SMAC based on liver injury. 
 90 ppm • 1/10 (species factor) • 120 h/168 h(time extrapolation) 
 7-day AC(Liver injury) = 6.4 ppm 
  
Equation 7: 30- and 180-day SMACs based on liver injury. 
 90 ppm • 1/10 (species factor) • 120 h/720 h(time extrapolation) 
 30- and 180-day AC(Liver injury)  = 1.5 ppm 
   
As reviewed previously, the toxicities of the C3-C8 aliphatic saturated aldehydes appear to be 
similar (James, 2000).  Upon review of the AC established for each toxicological endpoint, 
group SMACs were established for toxic effects by selecting the acceptable concentration for the 
most active compound for that endpoint.  Table 3 presents the individual ACs for each 
toxicological endpoint of concern.     
 
 
4 
  Table 3. Acceptable Concentrations for Identified Toxicological Endpoints - 2000 1 
End Point Uncertainty Factors    Acceptable Concentrations (ppm)   
 NOAEL Time Species Spaceflight  1 h 24 h 7 d 30 d 180 d 
Mucosal irritation 2-3 1 1 1  50 50 -- -- -- 
 10 1 1 1  -- -- 13 13 13 
Nasal-cavity injury 1 HR† 10 1  -- -- 50 27 -- 
 3 HR 10 1  -- -- -- -- 12 
Potential liver injury 1 HRthreshold 10 1  -- -- 6 1.5 1.5 
SMACs‡      50 50 6 1.5 1.5 
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† HR, Haber’s rule 
‡ SMACs for each exposure time are selected based on the most conservative AC for each toxicological endpoint  
 
 
SUMMARY OF NEW RELEVANT DATA FROM LITERATURE 
 
No toxicity studies at all (including those examining any relevant routes of pulmonary exposure) 
subsequent to 2000 having bearing on C3 to C8 aliphatic saturated aldehydes SMACs were 
located during this assessment.   
 
 
ADDITIONAL CONSIDERATION OF NON-TOXIC ODOR THRESHOLD 
The group of C3 to C8 aliphatic saturated aldehydes have varied odors described as agreeably 
fruity to choking and suffocating (NIOSH, 1994; Furia and Bellanca, 1975; Furia, 1980; U.S. 
Coast Guard, 1984-5; National Fire Protection Association, 1986).  The reported odor threshold 
for one aldehyde in this group, pentanal, is 0.028 ppm (pentanal was the only member of this 
group for which an odor threshold value is available; Amoore and Hautala, 1983).  A summary 
of reported odor characteristics for the C3 to C8 aliphatic saturated aldehydes is presented in 
Table 4. 
Odor thresholds – the lowest concentration of a chemical in the air that people can smell – are 
imprecise measurements.  Humans exhibit a naturally wide sensitivity to odors.  This sensitivity 
can be further affected by factors such as illness.  Because odor threshold detection can vary to a 
great extent, the concentrations are often reported as ranges.  Odor threshold values are not   
TABLE 4.  Selected Odor Characteristics of C3 to C8 Aliphatic Saturated Aldehydes. 
Compound Odor  Odor Threshold Reference 
Propanal Suffocating, fruity, similar to 
acetaldehyde, pungent, 
unpleasant, choking 
Not available NFPA,1986; Furia and 
Bellanca, 1975; 
USCG,1984-5; Furia,1980 
Butanal Pungent, aldehyde Not available Lewis, 1997 
Pentanal Powerful, acrid, pungent, 
strong 
0.028 ppm Amoore and Hautala, 1983; 
NIOSH, 1994 
Hexanal Fruity, strong green grass, 
sharp aldehyde 
Not available Furia and Bellanca, 1975; 
Furia,1980; Lewis, 1997 
Heptanal Fatty pungent, penetrating 
fruity 
Not available Furia,1980; Budavari, 1989 
Octanal Sharp fatty, fruity Not available Furia and Bellanca, 1975 
26 NFPA, National Fire Protection Association; USCG, U.S. Coast Guard; NIOSH, National Institute for Occupational Safety and Health 
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absolute points but rather an average of the sampled populations' response.  In addition, “fruity,” 
“chocking,” and “suffocating” are only descriptions of smells reported by individuals.  Detection 
of odor in the case of many chemicals can also be affected by continued exposure to that 
chemical odor.  Olfactory adaptation is a very common phenomena resulting from continued 
exposure to an odor and is characterized by a reduction or loss in smell sensitivity to a particular 
chemical (Pryor et al., 1970).  
Irritation threshold, demonstrated as the lowest concentration of a chemical causing acute 
stinging, burning sensations, or tear generation in the nose and eyes, is reported as irritation 
threshold values.  Irritation threshold values, which are distinctly different from odor thresholds, 
usually require higher ambient chemical concentrations to elicit an irritation response when 
compared to detection of odor (Amoore and Hautala, 1983).   Acetaldehyde, while not included 
in the group of C-3 to C-8 aldehydes, exhibits similar human irritancy to that of pentanal and 
propanal.  Like propanal, human subjects exposed for 30 minutes to 134 ppm acetaldehyde were 
reported to experience slight irritation (Sim and Pattle, 1957).  Acetaldehyde has a pungent 
suffocating odor with an odor threshold of 0.05 ppm and a TLV of 25 ppm which are again very 
similar to values for propanal and pentanal (ACGIH, 1999; U.S. EPA, 1987; Amoore and 
Hautala, 1983).  Amoore and Hautala (1983) reported an irritation threshold of 2,200 ppm for the 
nose and an ocular level of 11,000 ppm for acetaldehyde – approximately 44,000 times higher 
(nose) than the odor threshold value for this compound.  Both acetaldehyde and pentanal are 
classified by Amoore and Hautala (1983) as “Class A” substances, which because their odor 
threshold values are much lower than their respective threshold limit values, can serve as 
bellwether indicators. 
 
The low odor threshold of pentanal (and by inference, the other members of the C3-C8 
aldehydes) could serve as a means to alert the spacecraft crew to the presence of a substance at 
levels far lower than would be expected to cause toxicological effects.  Granted, crewmembers 
could experience smell aversion as a result of exposure to noxious chemical smells.  Although 
such aversion could impede crew performance, it should not be categorized as a toxic effect. 
Therefore odor threshold values are not utilized herein as a toxicological endpoint.  The odor 
threshold for pentanal (0.028 ppm) is several times higher than the lowest SMAC values for the 
C3 to C8 aldehydes (approximately 143 times higher).  Therefore, it is understood that the 
SMAC levels, which are designed to protect against adverse health effects, will not necessarily 
prevent spacecraft crewmember from experiencing smell aversion due to noxious odors.  A 
footnote will be included with the revised SMAC table describing the concentration where the 
odor of a representative compound – pentanal - may become a concern. 
 
 
REVISION OF EXISTING SMACs AND ESTABLISHMENT OF 1000-DAY SMAC  
 
After review of the studies considered in setting the original SMACs in 2000, the Committee on 
Spacecraft Exposure Guidelines has decided to revise all the ACs for the C3-C8 aldehydes. 
 
The uncertainty factor of “two to three” originally applied to the acute 1-h and 24-h SMAC in 
2000 will be revised to a factor of three.  A factor of three is considered the most conservative 
for this group of aldehydes and reflects animal data suggesting that some members of this group 
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of compounds are two to three times more irritating than the base compound – propanal (Salem 
and Cullumbine 1960; Abdo et al., 1998).  The 1-h and 24-h ACs remain based on the point of 
departure of 134 ppm (mildly irritating to mucosal surfaces after 30 min exposure in humans; 
Sim and Pattle, 1957).  Therefore, the revised 1-h and 24-h C3-C8 aldehyde SMACs are set at 45 
ppm (Eq. 8). 
 
Equation 8: Revised 1- and 24-h SMACs based on mucosal irritation. 
 134 ppm (LOAEL) x 1/3 
 1- and 24-h AC(Mucosal irritation) = 45 ppm 
 
The 2006 Committee revisited the original rational used in setting the 7- through 180-d SMACs 
in 2000.  In 2000, the long-term SMACs were predicated on protecting against liver pathology, 
which was based on acute (5-day) exposure data from rats (Gage, 1970).  The study reported by 
Gage utilized discontinuous exposures to propanal.  The 2000 SMACs subsequently utilized a 
factor to correct for continuous vs. discontinuous exposure conditions.  No additional factors 
were applied to account for exposure duration differences (i.e. 5 day to 7, 30, or 180 days) based 
on the assumption that a threshold dose - below which no liver pathology would occur – had 
been established.  However, upon reevaluation, the acute exposure protocol and the now 
questioned relationship between cellular vacuoles and liver pathology eliminated the use of the 
NOAEL reported by Cage as a point of departure for the longer-term SMACs.  The Committee 
chose instead to select the study of Abdo et al., 1998.  This stud design more closely corresponds 
to exposure durations bounded by the longer-term SMACs (7- through 1000-d).  In addition, the 
endpoint (squamous metaplasia of respiratory epithelium) was felt to be more toxicologically 
appropriate and defensible.   
 
Abdo et al employed exposure of rats and mice to select concentrations of isobutanal vapor for 6 
h/d, 5 d/wk for up to 13 weeks or 2 years.  The 13-week study revealed a NOAEL of 500 ppm in 
both rats and mice while the 2-year study revealed a LOAEL of 500 ppm in female rats.  The 
LOAEL of 500 ppm reported for female rats exposed for 2 years was selected as the point of 
departure for the 7-d through 1000-d SMACs.  A factor of ten was applied to extrapolate from a 
LOAEL to a NOAEL.  A correction factor of three was applied to account for interspecies 
differences in response.  Finally, a factor of three was applied as was the case for the new 1- and 
24-hr ACs (discussed previously) - to reflect animal data suggesting differences in irritating 
potential for these aldehydes (Salem and Cullumbine 1960; Abdo et al., 1998).  The revised 7-, 
30-, 180-d, and the new 1000-d SMACs are set at 4.5 ppm (Eq. 9).       
 
 Equation 9: 7-, 30-, 180-, 1000-d SMAC based on nasal-cavity injury. 
 500 ppm (LOAEL) • 1/10(LOAEL to NOAEL) • 1/3 (species factor) • 1/3 
 7- through 1000-d AC(Nasal-cavity injury)  = 4.5 ppm 
 
The 2006 SMACs for C3 to C8 aliphatic saturated aldehydes are presented in Table 5. 
 
 
 
 
7 
Table 5.  Spacecraft Maximum Allowable Concentrations (SMACs) for C3 to C8 Aliphatic 
Saturated Aldehydes - 2006 
1 
2 
Duration ppm mg/m3 Toxic Endpoint to Avoid 
1 h 45 113 Mucosal irritation 
24 h 45 113 Mucosal irritation 
7 d 4.5 11 Nasal-cavity injury 
30 d 4.5 11 Nasal-cavity injury 
180 d 4.5 11 Nasal-cavity injury 
1000 d 4.5 11 Nasal-cavity injury 
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Note: A representative average odor threshold concentration for the C3 to C8 aliphatic saturated aldehydes is 0.028 ppm (pentanal; Amoore and 
Hautala, 1983).  Some aldehydes in this group exhibit strong noxious odors detectable by humans at levels well below SMAC levels for these 
compounds. 
 
 
DIFFERENCES BETWEEN THE ORIGINAL AND CURRENT NATIONAL 
RESEARCH COUNCIL COMMITTEE ON TOXICOLOGY APPROACH 
 
The National Research Council Committee on Toxicology, as well as other regulatory bodies are 
primarily interested in using benchmark dose modeling (BMD) to interpret toxicological data.  
Favor of this relatively new tool over traditional threshold dose (NOAEL, LOAEL) data 
treatments is predicated on assumed advantages inherent in BMD application.  The NRC 
recommends that BMD methods be utilized when sufficient and appropriate dose-response data 
are available (NRC, 2000).  However, the NOAEL/ LOAEL-based method is recommended by 
the NRC in the absence of sufficient data or when special considerations are warranted. 
The current SMACs for C3 to C8 straight-chained, aliphatic aldehydes were established based on 
a LOAEL/NOAEL and safety factor method.  BMD methodology was applied to data from the 
long-term SMAC (7- through 1000-day) base study of Abdo et al., 1998.  A summary of the 
BMD analysis is presented below. 
 
Background for BMD analysis of long-term exposure data 
Isobutyraldehyde was administered to both sexes of F344/N rats and B6C3F1 mice by inhalation 
(6 hours per day, 5 days per week) for up to 13 weeks or two years (Abdo et al., 1998).  These 
results were used to the calculate benchmark concentration (BMC) for various toxic effects.  
Uncertainty factors were applied to the lower 95 % confidence limit of the benchmark 
concentration (BMCL) in order to arrive at maximum allowable concentrations.  These values 
are compared with the proposed current spacecraft maximum allowable exposure concentrations 
(SMACs). 
 
13-Week exposures reported by Abdo et al., 1998 
Ten animals per group were exposed to 0, 500, 1000, 2000, 4000, and 8000 ppm of 
isobutyraldehyde.  All rats died at 8000 ppm and 3 male and 6 female rats died at 4000 ppm.  All 
mice died at 4000 and 8000 ppm, except for one male mouse at 4000 ppm.  Body weight gains 
were reduced at 4000 ppm in both sexes of rats and reduced in both sexes of mice at 1000 ppm.  
Several endpoints could not be ascertained at 8000 ppm.  Hence, data from the 8000 ppm group 
were not used for estimating low-dose benchmark concentrations.  Incidence rates for the most 
sensitive endpoint for each sex of rats and mice are listed in Table 6.  
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Since the multistage (exponential polynomial) model can describe a wide variety of dose 
response shapes, it was used to estimate the dose response relationships.  BMCs and BMCLs 
associated with an excess risk of 10% are listed in Table 6.  Since a 10% incidence above 
background is the lowest rate that can be directly observed with 10 animals in a group, a 10% 
risk was selected for the BMC.  Further, with 10 animals per group, at least 4 animals are 
required with an effect in order to achieve a statistically significant increase (P≤0.05) above a 
background of 0 out of 10 animals.  Hence, using the BMCL10 as a point of departure for 
establishing a maximum allowable concentration is generally more conservative (stringent) than 
using the NOAEL.  
 
Table 6.  Incidence of effects in the most sensitive endpoint in each sex of rats and mice 
(10 animals per dose group) and estimates of BMC10 and BMCL10 for 13-week exposures. 
Exposure (ppm) BMC BMCL Species/Sex Endpoint 
0 500 1000 2000 4000 (ppm) 
Rat (male) 
Olfactory epithelium degeneration 
 
0 0 0 10 10 880 680 
Rat (female) 
Suppurative inflammation 
 
2 6 2 0 10 2030 1000 
Mice (male) 
Serous exudate 
 
0 2 0 4 10 1000 340 
Mice (female) 
Serous exudate 
0 0 0 3 10 1480 1020 
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Consistent with the calculation of SMACs, an uncertainty factor of 10 was used for interspecies 
extrapolation and no uncertainty factor is used for intraspecies variability or a potential risk at 
the point of departure (NOAEL or BMCL).  Further, adjustment for the duration of exposure 
employed Haber’s Rule which assumes equal toxic effects for equal cumulative exposures.  
Hence, experimental exposures of 6 hours per day for 5 days per week are assumed to be 
equivalent to continuous exposures of (6 / 24) x (5 / 7) = 0.18 times the exposure administered 
over the (13 x 7) = 91 days. 
   
The most sensitive endpoint, lowest BMCL10 = 340 ppm, occurred for serous exudate in male 
mice (Table 6).  This results in a 30-day SMAC of 
     
SMAC (30 days) = (340 / 10) x (6 / 24) x (5 / 7) x (91 / 30) = 18.4 ppm 
 
and a 180-day SMAC of 
 
SMAC (180 days) = (340 / 10) x (6 / 24) x (5 / 7) x (91 / 180) = 3.1 ppm. 
 
These results are complementary to the proposed SMAC of 4.5 ppm which is based on a 
LOAEL/NOAEL method. 
 
Further, average severity scores were examined using a polynomial model with the dose 
response data procedure for continuous data in the EPA Benchmark Dose Software (BMDS) 
program.  The most sensitive endpoint for severity was for olfactory epithelium degeneration in 
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male rats.  The benchmark response corresponding to an average severity grade of one (minimal 
effect) produced a BMCL = 1110 ppm, which exceeds the minimum BMCL = 340 ppm obtained 
for the incidences of effects. 
 
2-Year exposures reported by Abdo et al., 1998 
Initially, 50 animals per group were exposed to 0, 500, 1000, and 2000 ppm of isobutyraldehyde.  
Incidence rates for the most sensitive endpoint for each sex of rats and mice are listed in Table 7.  
Since the multistage (exponential polynomial) model can describe a wide variety of dose 
response shapes, it was used to estimate the dose response relationships.  BMCs and BMCLs 
associated with an excess risk of 5% are listed in Table 7.  With 50 animals per group, at least 5 
animals (10%) are required with an effect in order to achieve a statistically significant increase 
(P≤0.05) above a background of 0 out of 50 animals with the effect.  Hence, using the BMCL5 
as a point of departure for establishing a maximum allowable concentration is generally more 
conservative (stringent) than using the NOAEL. 
 
Table 7.  Incidence of effects and estimates of BMC5 and BMCL5 for 2-year exposures. 
Species/Sex Endpoint Exposure (ppm) BMC BMCL 
 0 500 1000 2000 (ppm) 
Respiratory epithelium 
squamous metaplasia 
      
Rat (male)  1/50† 1/49 10/49 44/50 590 450 
Rat (female) 1/49 11/50 9/49 44/50 270 150 
Olfactory epithelium degeneration       
Mice (male) 0/50 0/50 11/50 45/50 580 480 
Mice (female) 1/50 1/50 27/50 49/50 440 320 
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† observed / total 
 
Consistent with the calculation of SMACs, an uncertainty factor of 10 was used for interspecies 
extrapolation and no uncertainty factor is used for intraspecies variability or a potential risk at 
the point of departure (NOAEL or BMCL).  Further, adjustment for the duration of exposure 
employed Haber’s Rule which assumes equal toxic effects for equal cumulative exposures.  
Hence, experimental exposures of 6 hours per day for 5 days per week are adjusted by the factor 
(6 /24) x (5 / 7) for equivalency to continuous exposure. 
 
The most sensitive endpoint, lowest BMCL5 = 150 ppm, occurred for respiratory epithelium 
squamous metaplasia in female rats (Table 7.).  Presumably a 2-year lifetime exposure in rodents 
would be adequate to provide protection for a 1000-day exposure to humans.  The resulting 
1000-day SMAC is 
 
SMAC (1000 days) = (150 / 10) x (6 / 24) x (5 / 7) = 2.7 ppm. 
 
These results again are complementary to the proposed SMAC of 4.5 ppm which is based on a 
LOAEL/NOAEL method.    
 
Further, average severity scores were examined using a polynomial model with the dose 
response data procedure for continuous data in the EPA Benchmark Dose Software (BMDS) 
program.  The most sensitive endpoint for severity was for olfactory epithelium degeneration in 
female mice.  The benchmark response corresponding to an average severity grade of one 
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(minimal effect) produced a BMCL = 1420 ppm, which exceeds the minimum BMCL = 150 
ppm obtained for the incidences of effects. 
 
Summary of conclusions from BMD analyses 
Results from the 13-week exposures to isobutyraldehyde were used to calculate 30-day and 180-
day SMACs.  The most sensitive endpoint was the incidence of serous exudate in male mice 
giving 30-day and 180-day SMACs of 18.4 and 3.1 ppm, respectively.  The most sensitive 
endpoint from the 2-year exposures was the incidence of respiratory epithelium squamous 
metaplasia in female rats producing a 1000-day SMAC of 2.7 ppm.  The proposed 7 to 1000-day 
SMAC of 4.5 ppm, derived via application of a LOAEL/NOAEL method should provide 
protection for the effects observed in the study by Abdo et al. (1998). 
 
 
COMPARISON TO OTHER AIR QUALITY LIMITS 
 
Exposure guidelines for a limited subset of C3 to C8 aliphatic saturated aldehydes exist with 
various public-health and occupational-health entities as well as with industry and government 
advisory bodies.  Table 8 presents a list of some of these guidelines and regulatory standards for 
comparison to the current and proposed NASA SMACs.   
 
TABLE 8.  Selected Inhalation Exposure Levels for Selected C3 to C8 Aliphatic Saturated 
Aldehydes. 
Compound Organization  Exposure Guideline Exposure Level 
Propanal ACGIH (2004) TLV (8 h TWA) 20 ppm 
Pentanal ACGIH (2005) TLV (8 h TWA) 50 ppm 
Pentanal NIOSH (2005 REL (10 h TWA) 50 ppm 
Pentanal Australia (1990)  50 ppm 
Butanal AIHA (2001) WEEL (8 h TWA) 25 ppm 
C3-C8 aliphatic 
aldehydes NASA
† SMAC (1 h and 24 h) 45 ppm 
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37 
38 
39 
40 
ACGIH, American Conference of Governmental Industrial Hygienist; NIOSH, National Institute for Occupational Safety and Health; AIHA, 
American Industrial Hygiene Association; NASA, National Aeronautics and Space Administration; REL, Recommended Exposure Limit; TLV, 
Threshold Limit Value; WEEL, Workplace Environmental Exposure Level; SMAC, Spacecraft Maximum Acceptable Concentration 
† Only 1 h and 24 h SMACs are listed here for comparison to similar exposure duration guidelines from other organizations.  
 
The current NASA 1-h and 24-h SMACs are very similar to exposure levels from other 
organizations at comparable exposure durations.  Exposure limits and guidelines for pentanal 
(for which values are available for comparison) have remained stable for several years.  There 
are no guidelines available for long-term exposure durations to compare to the 7-, 30-, 180-, and 
1000-day SMACs.         
 
 
RECOMMENDATIONS FOR ADDITIONAL RESEARCH 
 
Shortcomings in the toxicity database pertaining to C3 to C8 aliphatic saturated aldehydes 
persists.  Lack of data concerning the effects of acute (humans) and chronic (humans and 
animals) exposures, as well as elucidation of non-lethal exposure effects to animals confounds 
attempts to establish exposure guidelines.  Recommendations for additional research pertaining 
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to toxicity of this group of aldehydes are unchanged from those proposed by James, 2000.  
Increasing the number of exposure concentrations employed as well as expansion of the endpoint 
measurements examined for all aldehydes in this group would be most beneficial.  The long-term 
exposure guidelines established herein are designed to protect against extra-pulmonary organ 
damage, specifically liver damage.  Long-term pulmonary studies would be beneficial in 
confirming and extending the work of Gage (1970) and validating the protective assumptions 
made in the establishment of our intermediate and long-term SMACs.   
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